Mar 17
|
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
|
Mar 17
|
Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?
|
Mar 16
|
Eli Lilly Just Had a Setback. Is Its Stock Still a Buy?
|
Mar 16
|
Eli Lilly Partners With Amazon's Pharmacy Business: Here's Why Both Stocks Should Win From the Deal
|
Mar 15
|
Wegovy and Zepbound Cast Shadow Over Madrigal’s Liver Drug
|
Mar 15
|
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time
|
Mar 15
|
Madrigal Can Market the First Drug for Obesity-Scarred Livers. The Stock Soars.
|
Mar 15
|
Pharma Stock Roundup: AZN's New Acquisition, FDA Updates for NVO & LLY and More
|
Mar 15
|
Can Eli Lilly Stock Double in 5 Years? Here's What It Would Take.
|
Mar 15
|
Move Over, Tesla! These 6 Stocks Could Replace It in the "Magnificent 7"
|
Mar 15
|
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
|
Mar 14
|
Amazon (AMZN) Boosts Pharmacy Efforts With Lilly's Partnership
|
Mar 14
|
20 States With the Healthiest Populations
|
Mar 14
|
Lilly (LLY) Partners Amazon to Deliver Drugs Like Zepbound
|
Mar 14
|
12 Most Profitable Biotech Stocks To Invest In
|
Mar 14
|
Should Investors Worry About Eli Lilly's Latest Regulatory Setback?
|
Mar 14
|
Tesla and Apple Are Dropping Out of the Mag 7, Where the Opportunities Are. And 5 Other Things to Know Before Markets Open.
|
Mar 13
|
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note
|
Mar 13
|
Healthcare Investors Aren’t Scared of Trump or Biden
|
Mar 13
|
Eli Lilly Taps Amazon's Pharmacy To Deliver Meds, Including Weight-Loss Drug Zepbound
|